KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Gains from Investment Securities (2016 - 2025)

Encompass Health (EHC) has disclosed Gains from Investment Securities for 17 consecutive years, with -$8.1 million as the latest value for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 113.16% year-over-year to -$8.1 million; the TTM value through Mar 2026 reached -$18.2 million, down 130.85%, while the annual FY2025 figure was $4.1 million, 81.19% down from the prior year.
  • Gains from Investment Securities hit -$8.1 million in Q4 2025 for Encompass Health, up from -$14.3 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $48.6 million in Q2 2021 and bottomed at -$32.0 million in Q3 2021.
  • Average Gains from Investment Securities over 5 years is $3.0 million, with a median of -$350000.0 recorded in 2022.
  • Year-over-year, Gains from Investment Securities surged 956.52% in 2021 and then tumbled 1141.67% in 2024.
  • Encompass Health's Gains from Investment Securities stood at -$12.0 million in 2021, then skyrocketed by 104.17% to $500000.0 in 2022, then plummeted by 1120.0% to -$5.1 million in 2023, then grew by 25.49% to -$3.8 million in 2024, then plummeted by 113.16% to -$8.1 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$8.1 million, -$14.3 million, and $4.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.